论文信息 - Benznidazole in Chagas disease study: do the data justify progression to phase 3? - Authors' reply. - 字舞流文

Benznidazole in Chagas disease study: do the data justify progression to phase 3? - Authors' reply.

Nathalie Strub-Wourgaft | F. Torrico | S. Sosa-Estani | Fabiana Barreira | Isabella Ribeiro

[1] M. Vaillant,et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. , 2021, The Lancet. Infectious diseases.

[2] J. Kratz,et al. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease , 2018, Expert review of clinical pharmacology.

[3] G. Koren,et al. Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults , 2014, PLoS neglected tropical diseases.